* NU Skin Enterprises Inc NUS.N NUS is expected to show
a fall
in quarterly revenue when it reports results on February 14 for
the period ending December 31 2023
* The Provo Utah-based company is expected to report a
8.8% decrease in revenue to $476.389 million from $522.34
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.The company's guidance on November
1 2023, for the period ended December 31, was for revenue
between $440.00 million and $480.00 million.
* LSEG's mean analyst estimate for NU Skin Enterprises Inc
is for
earnings of 28 cents per share. The company's EPS guidance on
November 1 2023, for the period ended December 31, was between
$0.15 and $0.30
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NU Skin
Enterprises Inc is $20.50, above its last closing price
of $17.60.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.62 0.62 0.56 Missed -10.3
Jun. 30 2023 0.53 0.53 0.54 Beat 1.3
Mar. 31 2023 0.33 0.33 0.37 Beat 12.2
Dec. 31 2022 0.53 0.53 0.89 Beat 66.4
Sep. 0.78 0.78 0.47 Missed -39.6
30 2022
Jun. 30 2022 0.76 0.75 0.77 Beat 2.3
Mar. 31 2022 0.72 0.72 0.76 Beat 5.8
Dec. 31 2021 0.95 0.95 1.11 Beat 17.3
This summary was machine generated February 12 at 21:29 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)